Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NFX-179 Gel in Cutaneous Neurofibromas
NCT04435665Phase 2Completed
- Sponsor
- NFlection Therapeutics
- Start
- Aug 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NFX-179 Gel in cutaneous neurofibroma (cNF), sponsored by NFlection Therapeutics. Started Aug 2020; status: completed.
02
Drugs
NFX-179 Gel
03
Conditions
cutaneous neurofibroma (cNF)
Beyond the preview
Go deeper on NCT04435665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04435665.